KRAS and neoplasm: By contrast, KRAS tumors lacking these co-alterations more often exhibit inflammatory T-cell infiltration (“immune hot”) and can respond favorably to checkpoint inhibitors, underscoring the interaction between tumor-intrinsic circuitry and antitumor immunity [34,90].